01628oam 2200385 450 991070799230332120170815085422.0(CKB)5470000002468642(OCoLC)968792727(EXLCZ)99547000000246864220170117d2016 ua 0engurbn||||a||||txtrdacontentcrdamediacrrdacarrierExamining implementation of the Biologics Price Competition and Innovation Act hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016Washington :U.S. Government Publishing Office,2016.1 online resource (iii, 83 pages)Paper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office."Serial No. 114-114."Includes bibliographical references.Examining implementation of the Biologics Price Competition and Innovation Act BiologicalsGovernment policyUnited StatesPharmaceutical biotechnologyGovernment policyUnited StatesLegislative hearings.lcgftBiologicalsGovernment policyPharmaceutical biotechnologyGovernment policyGPOGPOGPOBOOK9910707992303321Examining implementation of the Biologics Price Competition and Innovation Act3526765UNINA